Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.
about
Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug deliveryThe effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaPharmacokinetics of antiretrovirals in mucosal tissueAlterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.Model-Based Analysis of Unbound Lopinavir Pharmacokinetics in HIV-Infected Pregnant Women Supports Standard Dosing in the Third Trimester.Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda.The right compound in the right assay at the right time: an integrated discovery DMPK strategy.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats.Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir.Identification of cytochrome P450s involved in the metabolism of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1) using human recombinant enzymes and rat liver microsomes in vitro.Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.
P2860
Q28081272-9C46FF87-DCEC-41AE-A347-087D7A4D628FQ35154032-0E8D6BA3-7D05-4A53-BDBB-F95F231A5757Q35838594-7E7BCECE-9919-4A2A-973A-1BC293B73A2CQ36288425-58782E17-3B4B-4EDB-B925-8DCCA7605CB9Q36289127-8B6CC941-8AF0-4E2E-883D-F74DE70DE823Q36620507-01C0AA35-CA21-4DBD-AF23-03BCC350E018Q36727919-E31E1C63-F880-493B-9E57-FAB3477AC26DQ37203653-EA07DA97-01E5-4DF3-874F-2F0A130A1391Q37251993-8F627E67-0B06-4F3C-A99C-C1B1FE8F7C07Q37325606-DEC7C07B-9BBF-4522-925B-30C27B9BE523Q37600844-1A6B4D54-E6FE-4A67-8978-EFA9716C5A32Q38018653-FE201ACD-5DA7-496A-9E2F-9E2B90AAB8E0Q38051400-DE1F22BA-CC65-48D0-9D6B-685E4AF38FA6Q38324557-A912BCD2-94A3-45AD-A8A6-8AA6A2CF5E4FQ39311308-2F4709D0-2951-465B-AC67-2E75F9121568Q39883877-D9CEE863-9A1C-42D0-8C57-74C23547DD62Q40755393-EFB53B44-B948-4115-9CC6-48F43578FDA5Q47135716-5EC801E0-F137-4DE7-92D4-5B6EA045FF2DQ51031739-E90C8BF7-0B07-479D-B3DD-47ED96029E83Q54267469-498733F3-4296-42C0-955C-9EAEFADB63F2
P2860
Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@en
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@nl
type
label
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@en
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@nl
prefLabel
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@en
Influence of drug transport pr ...... ns of HIV protease inhibitors.
@nl
P2860
P356
P1476
Influence of drug transport pr ...... ons of HIV protease inhibitors
@en
P2093
Latoya Griffin
P2860
P304
P356
10.1002/JPS.22655
P407
P577
2011-06-22T00:00:00Z